Search
CAR-T Therapy Demonstrates Remarkable Improvement in Outcomes for Advanced Gastric Cancer
1 day ago /
Read about 0 minute
Author：小编
A Phase II clinical study, published by Chinese researchers in The Lancet, has unveiled groundbreaking advancements in the application of CAR-T therapy for the treatment of malignant solid tumors. Compared to conventional treatment methods, CAR-T therapy has shown potential to markedly prolong progression-free survival in patients with advanced cancer. CAR-T represents a cutting-edge immunotherapy that leverages genetic engineering to modify a patient's T cells, empowering them to identify and eliminate specific tumor cells. While this therapy has traditionally been utilized primarily for hematological malignancies, this latest breakthrough in treating solid tumors signifies a significant milestone.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
